Drug
Rm-2 ga-68 clinical trials
Also written BAY 86-7548 and 68Ga-RM2.
- studies test it
- 10
- open now
- 1
- in phase 3
- 1
- first study started
- 2015
Keep track of what changes. Save the rm-2 ga-68 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 10
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 9
Andrei Iagaru (6) · IRCCS San Raffaele (2) · Stanford University (1) · Life Molecular Imaging SA (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses rm-2 ga-68 is read from its arms, and is right about nine times in ten.
Testing it · 10
- PET/MRI to Stage Prostate Cancer PatientsRecruitingPhase 2IRCCS San RaffaeleNCT06484361Written as 68Ga-RM2
- HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate CancerTerminatedPhase 2Andrei IagaruNCT04264208Written as 68-Ga RM2.
- 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU TherapyCompletedPhase 1/2Andrei IagaruNCT03949517Written as 68-Ga RM2
- 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate CancerCompletedPhase 2Andrei IagaruNCT03809078Written as 68Ga RM2
- 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast CancerCompletedPhase 1/2Andrei IagaruNCT03831711Written as Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
- 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate CancerCompletedPhase 2Andrei IagaruNCT03113617Written as Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
- 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate CancerCompletedPhase 2/3Andrei IagaruNCT02624518Written as 68Ga-RM2
- PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric StudyCompletedPhase 2IRCCS San RaffaeleNCT05806853Written as 68Ga-RM2
- 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate CancerCompletedPhase 2Stanford UniversityNCT02440308Written as 68Ga-DOTA-Bombesin
- PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate CancerTerminatedPhase 1/2Life Molecular Imaging SANCT02483884Written as [68Ga]RM2
As the comparator · 1 — what is tested is compared with rm-2 ga-68
Codes
What other systems call rm-2 ga-68 · ClinicalTrials.gg INT006321
- UNII (FDA) NPI2H5M36DRM-2 GA-68One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NPI2H5M36D | RM-2 GA-68 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.